With new support from the National Institutes of Health, a team of researchers at the Wisconsin Institute of Discovery will lead drug therapeutics testing for two diseases known to cause blindness....
A drug used in people in the early stage of the most common kind of breast cancer – HR+/HER2- breast cancer – significantly reduced the risk of the cancer returning after treatment, according to a new study....
University of Wisconsin Carbone Cancer Center will be designated as a Specialized Program of Research Excellence, or SPORE, by the National Cancer Institute (NCI) for research initiatives to advance new prostate cancer treatments....
In order to advance precision medicine, we need to focus on improving outreach to and the experience of patients....
Researchers with the UW Carbone Cancer Center are developing AI techniques to improve personalized treatments for brain cancer and to avoid unnecessary biopsies and surgeries....
In the last six months, multiple clinical trials have brought the idea of a preventative breast cancer vaccine much closer to reality....
The UW Clinical Trials Institute will seek to bolster consistency, quality and safety not to mention optimized resource allocation as UW-Madison ramps up its competitive position in the academic medical research ecosystem....
An NIH-funded research team led by Dr. Vinod Balachandran from Memorial Sloan Kettering Cancer Center (MSKCC) have been developing a personalized mRNA cancer-treatment vaccine approach....
Researchers at the University of Wisconsin–Madison’s Center for Healthy Minds are leveraging artificial intelligence to deliver personalized well-being content through a person’s mobile device when they need it most....
Creating functional organoids from a patient’s tumor tissue allows researchers to test different treatment options in a realistic environment to predict what’s most likely to benefit that patient....
